Back to Search
Start Over
Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV
- Source :
- Alimentary pharmacologytherapeutics. 43(7)
- Publication Year :
- 2016
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
Daclatasvir
Sofosbuvir
Hepacivirus
Gastroenterology
Antiviral Agents
Treatment experienced
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Genotype 1b
Internal medicine
Ribavirin
medicine
Humans
Pharmacology (medical)
Hepatology
biology
business.industry
Hepatitis C
biology.organism_classification
medicine.disease
030104 developmental biology
chemistry
030211 gastroenterology & hepatology
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 13652036
- Volume :
- 43
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Alimentary pharmacologytherapeutics
- Accession number :
- edsair.doi.dedup.....53c15e523ad5b6b205733fe6f5d4ae2c